Grab 20% Off With Code ONLINE20 On Global market Reports – Evaluate Global Trends, Market Risks, and Competitive Intelligence
How Has the Neurointerventional Devices Market Performed Historically, and What Are Its Future Growth Projections?
The neurointerventional devices market size has grown strongly in recent years. It will grow from $2.57 billion in 2024 to $2.76 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing awareness of early diagnosis, a growing number of specialized neurointerventional centers, increasing prevalence of lifestyle-related diseases such as hypertension and diabetes, a rise in demand for improved patient outcomes, and growing support from public and private health organizations.
The neurointerventional devices market size is expected to see strong growth in the next few years. It will grow to $3.65 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to growing preference for image-guided surgeries, rising investment in neurovascular research, increasing approval of novel neurointerventional products, growing partnerships and acquisitions among device manufacturers, and rising demand for personalized treatment approaches. Major trends in the forecast period include advancement in robotic-assisted neurointerventions, innovation in catheter and stent design, advanced integration of artificial intelligence in diagnostic imaging, integration of augmented reality in surgical planning, and innovation in embolization and thrombectomy techniques.
Get your free report sample today:
What Are the Major Growth Drivers for the Neurointerventional Devices Market?
The rising incidence of neurological disorders is expected to propel the growth of the neurointerventional devices market going forward. A neurological disorder refers to any condition that affects the brain, spinal cord, or nerves, disrupting normal functioning. The increase in neurological disorders is driven by an aging global population, as advancing age increases the risk of neurodegenerative conditions due to the natural decline in brain function and cellular repair mechanisms. Neurointerventional devices help treat neurological disorders by enabling minimally invasive procedures to diagnose and manage conditions such as brain aneurysms, strokes, and vascular malformations, thereby reducing risk and recovery time and improving patient outcomes. For instance, in April 2024, according to a report by the Alzheimer's Association, a US-based nonprofit voluntary health organization, in 2022, 6.5 million Americans aged 65 and older were diagnosed with Alzheimer's dementia, increasing to 6.9 million in 2024. Therefore, the rising incidence of neurological disorders is driving the growth of the neurointerventional devices market.
What Are the Major Segments Defining the Structure of the Neurointerventional Devices Market?
The neurointerventional devices market covered in this report is segmented –
1) By Product: Embolic Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy, Embolic Protection Device, Flow Diverters Device, Intrasaccular Device, Other Products
2) By Indication: Brain Aneurysm, Stroke, Other Indications
3) By Technique: Neurothrombectomy Procedure, Cerebral Angiography, Stenting, Coiling Procedures, Flow Disruption
4) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research Institutes
Subsegments:
1) By Embolic Coils: Bare Platinum Coils, Coated Or Modified Coils, Complex-Shaped Coils, Detachable Coils
2) By Carotid Stents: Open-Cell Stents, Closed-Cell Stents, Hybrid-Cell Stents, Drug-Eluting Stents
3) By Intracranial Stents: Self-Expanding Stents, Balloon-Expandable Stents, Drug-Eluting Stents
4) By Neurovascular Thrombectomy Devices: Stent Retrievers, Aspiration Catheters, Combined Thrombectomy Systems
5) By Embolic Protection Devices: Distal Filters, Proximal Occlusion Devices, Distal Occlusion Devices
6) By Flow Diverters Devices: Braided Flow Diverters, Dual-Layer Flow Diverters, Coated Flow Diverters
7) By Intrasaccular Devices: Woven Mesh Implants, Expandable Mesh Baskets, Flow Disrupting Implants
8) By Other Products: Microcatheters, Guidewires, Balloon Catheters, Distal Access Catheters
What Are the Key Industry Trends Driving Growth in the Neurointerventional Devices Market?
Major companies operating in the neurointerventional devices market are focusing on technological advancements such as AI-assisted navigation systems to enhance procedural precision, reduce intervention time, and improve patient outcomes in complex neurovascular treatments. AI-assisted navigation systems refer to advanced technologies that use artificial intelligence algorithms to guide neurointerventional procedures in real time. These systems analyze medical imaging data to provide enhanced visualization, automate path planning, and assist in accurately navigating devices through complex brain vasculature, thereby improving precision, reducing procedure time, and minimizing risks. For instance, in October 2022, Medtronic plc, an Ireland-based healthcare technology company, launched the Medtronic Neurovascular Co Lab Platform to accelerate innovation in stroke treatment. The platform fosters collaboration among startups, physicians, and institutions, offering an always-on virtual portal for idea submissions, which are evaluated and advanced through access to Medtronic’s expertise, funding, and networks to rapidly develop promising neurovascular solutions and improve patient outcomes.
Which Companies Hold a Prominent Position in the Neurointerventional Devices Market?
Major companies operating in the neurointerventional devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Kaneka Corporation, Cook Medical LLC, Integra LifeSciences Holdings Corporation, Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., Asahi Intecc Co. Ltd., MicroVention Inc., Phenox GmbH, Balton Sp. z o.o., Zylox-Tonbridge Medical Technology Co. Ltd., Balt Group SAS, Veiva Scientific Co. Ltd., InspireMD Inc.
Get the detailed neurointerventional devices market report today
What Are the Fastest-Growing Regions in the Neurointerventional Devices Market?
North America was the largest region in the neurointerventional market in 2024. The regions covered in the neurointerventional devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment